Premium
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial
Author(s) -
Fleminger J,
Seed PT,
Smith A,
Juszczak E,
Dixon PH,
Chambers J,
Dorling J,
Williamson C,
Thornton JG,
Chappell LC
Publication year - 2021
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.16567
Subject(s) - ursodeoxycholic acid , cholestasis of pregnancy , bile acid , medicine , cholestasis , gastroenterology , subgroup analysis , statistical significance , pregnancy , population , confidence interval , fetus , biology , genetics , environmental health
Objective To evaluate whether a particular group of women with intrahepatic cholestasis of pregnancy (ICP), based on their presenting characteristics, would benefit from treatment with ursodeoxycholic acid (UDCA). Design Secondary analysis of the PITCHES trial (ISRCTN91918806). Setting United Kingdom. Population or Sample 527 women with ICP. Methods Subgroup analyses were performed to determine whether baseline bile acid concentrations or baseline itch scores moderated a woman’s response to treatment with UDCA. Main outcome measures Bile acid concentration and itch score. Results In women with baseline bile acid concentrations less than 40 μmol/l, treatment with UDCA resulted in increased post‐randomisation bile acid concentrations (geometric mean ratio 1.19, 95% CI 1.00–1.41, P = 0.048). A test of interaction showed no significance ( P = 0.647). A small, clinically insignificant difference was seen in itch response in women with a high baseline itch score (–6.0 mm, 95% CI −11.80 to −0.21, P = 0.042), with a test of interaction not showing significance ( P = 0.640). Further subgroup analyses showed no significance. Across all women there was a weak relationship between bile acid concentrations and itch severity. Conclusions There was no subgroup of women with ICP in whom a beneficial effect of treatment with UDCA on bile acid concentration or itch score could be identified. This confirms that its routine use in women with this condition for improvement of bile acid concentration or itch score should be reconsidered. Tweetable abstract PITCHES: No group of women with ICP has been found in whom UDCA reduces bile acid concentrations or pruritus.